More

    Europe Markets

    Fortacin | European Medicines Agency (EMA)

    OverviewFortacin is used to treat men with primary (lifelong) premature ejaculation (when ejaculation regularly occurs before, or too early during, penetration).Fortacin contains the...
    Europe Markets

    Trazimera | European Medicines Agency (EMA)

    OverviewTrazimera is a cancer medicine used to treat the following conditions:early breast cancer (when the cancer has spread within the breast or to...
    Europe Markets

    Obizur | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Obizur. It explains how the Agency assessed the medicine to recommend...
    Europe Markets

    Zomarist | European Medicines Agency (EMA)

    OverviewZomarist is a diabetes medicine that is used together with diet and exercise to control the blood glucose (sugar) in adults with type...
    Europe Markets

    Zykadia | European Medicines Agency (EMA)

    OverviewZykadia is a cancer medicine used on its own to treat adults with a type of lung cancer called non-small-cell lung cancer (NSCLC),...
    Europe Markets

    Emtricitabine/Tenofovir disoproxil Krka | European Medicines Agency (EMA)

    OverviewEmtricitabine/Tenofovir disoproxil Krka is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults infected...
    Europe Markets

    Flucelvax Tetra | European Medicines Agency (EMA)

    OverviewFlucelvax Tetra is a vaccine used to protect adults and children from 2 years of age against influenza (flu).Influenza is mainly caused by...
    Europe Markets

    Abraxane | European Medicines Agency (EMA)

    OverviewThis is a summary of the European Public Assessment Report (EPAR) for Abraxane. It explains how the Committee for Medicinal Products for Human...
    Europe Markets

    Piqray | European Medicines Agency (EMA)

    OverviewPiqray is a cancer medicine used to treat postmenopausal women and men with breast cancer that is locally advanced or has spread to...
    Europe Markets

    One Health approach | European Medicines Agency (EMA)

    The European Medicines Agency (EMA) and four other health and environment agencies of the European Union (EU) work together to implement the One...
    Europe Markets

    Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)

    OverviewThis is a summary of the European public assessment report (EPAR) for Irbesartan Hydrochlorothiazide Zentiva. It explains how the Committee for Medicinal Products...
    Europe Markets

    Celldemic | European Medicines Agency (EMA)

    OverviewCelldemic is a vaccine used to protect adults and children from 6 months of age against influenza (flu) caused by the H5N1 subtype...
    Europe Markets

    Irbesartan Zentiva (previously Irbesartan Winthrop)

    OverviewThis is a summary of the European public assessment report (EPAR) for Irbesartan Zentiva. It explains how the Committee for Medicinal Products for...
    Europe Markets

    Rivastigmine 1 A Pharma | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
    Europe Markets

    Teriflunomide Viatris (previously Teriflunomide Mylan)

    OverviewTeriflunomide Viatris is a medicine used to treat patients from the age of 10 years with multiple sclerosis (MS), a disease in which...
    Europe Markets

    Darunavir Krka | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Darunavir Krka. It explains how the Agency assessed the medicine to...
    Europe Markets
    1...111213...16Page 12 of 16

    © 2025 Liberte